MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Exploiting sequence data of genes involved in synthesis of plant derived enzyme inhibitors of Acetylcholinesterase that involve in antineurodegenerative acitivity.

    N. No surname, M. Abdin (New Delhi, India)

    Objective: Sequence analysis of genes involved in acetylcholinesterase inhibitors biosynthesis from various plant species Background: The neurodegenerative disease like Alzheimer’s disease and Parkinson’s disease involve…
  • 2017 International Congress

    Сase of myotonic dystrophy

    A. Jusupova (Bishkek, Kyrgyzstan)

    Objective: Myotonic dystrophy (dystrophia myotonica, DM) is the most frequently inherited neuromuscular disease of adult life.  Background: Classical DM (DM1) has been identified as an…
  • 2017 International Congress

    Salivary biomarkers for Huntington’s disease (HD)

    J. Corey-Bloom, A. Aikin, S. Park, A. Haque, A. Nathan, D. Granger, S. Granger, E. Thomas (La Jolla, CA, USA)

    Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…
  • 2017 International Congress

    Inhibiting sphingosine-1-phosphate lyase as a possible therapy in Huntington’s disease

    E. Furr Stimming, J.F. Manchon, A. Tsvetkov (Houston, TX, USA)

    Objective:  To advance our understanding of the process by which the mutant huntingtin (mHTT) protein contributes to neurodegeneration and translate that knowledge to potentially effective disease…
  • 2017 International Congress

    Social hindrances for diagnosing Huntington’s disease

    A. Alboudi, P. Sarathchandran, A.B. Almadani (Dubai, United Arab Emirates)

    Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
  • 2017 International Congress

    GBA mRNA is diminished in brain and blood of Lewy body diseases

    K. Beyer, J. Campdelacreu, L. Ispierto, D. Vilas, R. Reñé, R. Alvarez (Badalona, Spain)

    Objective: To find out whether GBA deficiency starts at the transcriptional level and if it also involves alternative splicing. To study GBA expression changes in…
  • 2017 International Congress

    Neuroprotective Potency of Tetrahydroisoquinoline a Novel Ayurveda Molecule in Experimental Parkinson’s Disease

    R. Banerjee, D. Nthenge-Ngumbau, R. Singh, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)

    Objective: Tetrahydroisoquinoline (TIQ) an identified alkaloid from ancient Indian ‘Ayurveda’ medicine for Parkinson’s disease (PD) was tested for neuroprotection in a cellular system and a…
  • 2017 International Congress

    Relationship of metabolic markers in Parkinson’s disease

    N. Alsomali, A. Mujtaba, A. AlSamrani, S. Marar, T. Mohammad (Riaydh, Saudi Arabia)

    Objective: To investigate the relationship of obesity, Hypertension (HTN), Ischemic heart disease (IHD), Dyslipidemia (DLP), and Diabetes Mellitus (DM) with PD. Background: Parkinson’s disease (PD)…
  • 2017 International Congress

    Impaired intracortical inhibition is associated with reduced hand dexterity in Parkinson’s disease patients

    S. Filipović, A. Kačar, S. Milanović, M. Ljubisavljević, V. Kostić (Beograd, Serbia)

    Objective: To check whether hand dexterity in Parkinson’s disease (PD) patients is linked with motor cortex excitability and plasticity. Background: Hand dexterity is impaired in…
  • 2017 International Congress

    Expression of late cell cycle markers in Parkinson Disease and Lewy Body Dementia

    I. Martinez-Valbuena, R. Valenti-Azcarate, M.M. Carmona-Abellan, I. Marcilla-Garcia, I. Gaston-Zubimendi, G. Marti-Andres, M.-T. Tuñon-Alvarez, M.-R. Luquin-Piudo (Pamplona, Spain)

    Objective: The objective of this study is to determine the expression of late cell cycle markers in Parkinson Disease (PD) and Lewy Body Dementia (LBD) Background:…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley